148 related articles for article (PubMed ID: 19742144)
1. 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.
Abou El Fadl MH; Bagai RK; Spiro TP; Daw HA
Gastrointest Cancer Res; 2009 Jul; 3(4):167-70. PubMed ID: 19742144
[No Abstract] [Full Text] [Related]
2. Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients.
Jin X; Bai Y; Gao L; Wu S
Cancer Chemother Pharmacol; 2019 Sep; 84(3):599-607. PubMed ID: 31203389
[TBL] [Abstract][Full Text] [Related]
3. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
[No Abstract] [Full Text] [Related]
4. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
Crawley C; Ross P; Norman A; Hill A; Cunningham D
Br J Cancer; 1998 Aug; 78(4):508-10. PubMed ID: 9716035
[TBL] [Abstract][Full Text] [Related]
5. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
6. ["Iatrogenic acute coronary syndrome"--59 year old patient with adenocarcinoma of ascending colon and stenocardia while receiving adjuvant chemotherapy with 5-fluorouracil].
Gundling F; Fuchs M; Nowak L; Antoni D; Hoffmann E; Schepp W
Z Gastroenterol; 2006 Sep; 44(9):975-9. PubMed ID: 16981070
[TBL] [Abstract][Full Text] [Related]
7. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Zaanan A; Gauthier M; Malka D; Locher C; Gornet JM; Thirot-Bidault A; Tougeron D; Taïeb J; Bonnetain F; Aparicio T;
Cancer; 2011 Apr; 117(7):1422-8. PubMed ID: 21425142
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
Gibson MK; Holcroft CA; Kvols LK; Haller D
Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
[TBL] [Abstract][Full Text] [Related]
9. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
Saif MW; Garcon MC; Rodriguez G; Rodriguez T
In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Heart-Type Fatty Acid-Binding Protein and Myocardial Performance Index for Early Detection of 5-Fluorouracil Cardiotoxicity.
Turan T; Agac MT; Aykan AÇ; Kul S; Akyüz AR; Gökdeniz T; Gül İ; Cengiz E; Boyacı F; Erkan H; Akdemir R; Celik S
Angiology; 2017 Jan; 68(1):52-58. PubMed ID: 26980771
[TBL] [Abstract][Full Text] [Related]
12. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
[TBL] [Abstract][Full Text] [Related]
13. Small bowel adenocarcinoma metastatic to the ovaries in a 12-year-old girl.
Dunsmore KP; Lovell MA
J Pediatr Hematol Oncol; 1998; 20(5):498-501. PubMed ID: 9787329
[TBL] [Abstract][Full Text] [Related]
14. Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.
Köhne CH; Thuss-Patience P; Friedrich M; Daniel PT; Kretzschmar A; Benter T; Bauer B; Dietz R; Dörken B
Br J Cancer; 1998 Mar; 77(6):973-7. PubMed ID: 9528843
[TBL] [Abstract][Full Text] [Related]
15. Acute severe coronary spasm associated with initial first dose of 5-fluorouracil chemotherapy.
Mariani G; Giaccon G; Mastore M
Ital Heart J; 2003 Aug; 4(8):568-70. PubMed ID: 14564986
[TBL] [Abstract][Full Text] [Related]
16. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.
Fishman PN; Pond GR; Moore MJ; Oza A; Burkes RL; Siu LL; Feld R; Gallinger S; Greig P; Knox JJ
Am J Clin Oncol; 2006 Jun; 29(3):225-31. PubMed ID: 16755174
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil Rechallenge After Cardiotoxicity.
Desai A; Mohammed T; Patel KN; Almnajam M; Kim AS
Am J Case Rep; 2020 Aug; 21():e924446. PubMed ID: 32860674
[TBL] [Abstract][Full Text] [Related]
18. Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer.
Franck C; Malfertheiner P; Venerito M
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536214
[TBL] [Abstract][Full Text] [Related]
19. [Cardiotoxicity of 5-fluorouracil. Clinical relevance of palliative radiochemotherapy of malignant head-neck tumors].
Heib C; Schmidt HJ; Heib T; Lüer B; Stasche N
Laryngorhinootologie; 2001 May; 80(5):249-52. PubMed ID: 11417246
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity resembling myocardial infarction that occurs during chemotherapy with 5-fluorouracil.
Gul M; Duzenli A; Bircan M; Cander B; Kocak S; Ozdemir K
Saudi Med J; 2005 Nov; 26(11):1821-2. PubMed ID: 16311676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
